1. Home
  2. ALLR vs MEGL Comparison

ALLR vs MEGL Comparison

Compare ALLR & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • MEGL
  • Stock Information
  • Founded
  • ALLR 2004
  • MEGL 2016
  • Country
  • ALLR United States
  • MEGL Hong Kong
  • Employees
  • ALLR N/A
  • MEGL N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • MEGL Finance: Consumer Services
  • Sector
  • ALLR Health Care
  • MEGL Finance
  • Exchange
  • ALLR Nasdaq
  • MEGL Nasdaq
  • Market Cap
  • ALLR 13.3M
  • MEGL 5.7M
  • IPO Year
  • ALLR N/A
  • MEGL 2022
  • Fundamental
  • Price
  • ALLR $1.02
  • MEGL $1.75
  • Analyst Decision
  • ALLR
  • MEGL
  • Analyst Count
  • ALLR 0
  • MEGL 0
  • Target Price
  • ALLR N/A
  • MEGL N/A
  • AVG Volume (30 Days)
  • ALLR 448.4K
  • MEGL 3.1M
  • Earning Date
  • ALLR 08-04-2025
  • MEGL 07-01-2025
  • Dividend Yield
  • ALLR N/A
  • MEGL N/A
  • EPS Growth
  • ALLR N/A
  • MEGL N/A
  • EPS
  • ALLR N/A
  • MEGL N/A
  • Revenue
  • ALLR N/A
  • MEGL $1,645,862.00
  • Revenue This Year
  • ALLR N/A
  • MEGL N/A
  • Revenue Next Year
  • ALLR N/A
  • MEGL N/A
  • P/E Ratio
  • ALLR N/A
  • MEGL N/A
  • Revenue Growth
  • ALLR N/A
  • MEGL N/A
  • 52 Week Low
  • ALLR $0.61
  • MEGL $1.02
  • 52 Week High
  • ALLR $10.59
  • MEGL $5.52
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 51.07
  • MEGL 56.36
  • Support Level
  • ALLR $0.80
  • MEGL $1.46
  • Resistance Level
  • ALLR $0.98
  • MEGL $1.77
  • Average True Range (ATR)
  • ALLR 0.06
  • MEGL 0.24
  • MACD
  • ALLR 0.01
  • MEGL 0.02
  • Stochastic Oscillator
  • ALLR 69.64
  • MEGL 32.61

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

Share on Social Networks: